A hepatocellularis carcinoma - A makroszkópiától a molekuláris patológiáig

Translated title of the contribution: Hepatocellular carcinoma - From macroscopy to molecular pathology

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is a tumor with rather bad prognosis. Recent years, however, have seen considerable progress in the diagnostics and treatment of this disease, contributing to better understanding of its molecular pathogenesis. Large regenerative nodules, low and high grade dysplastic nodules are premalignant alterations of HCC developing on the grounds of cirrhosis. Microscopically the WHO distinguishes trabecular, acinar (pseudoglandular), scirrhous and solid forms. Special histological subtypes are the clear cell, fibrolamellar and mixed hepato-cholangiocellular variants. The prognostic significance of these histological types is argued. The fibrolamellar, non-cirrhotic form of HCC occurring in young age is considered to be of better prognosis, but this is probably due to the fact that this type is not accompanied by cirrhosis. Certain tumor markers may help the diagnosis, such as alpha-fetoprotein (AFP), glypican-3, survivin, the recently described agrin and claudins, furthermore, the hepatocyte specific antigen (HSA), which confirms the hepatocytic origin of the tumor. Recently, the diagnostic significance of microRNAs, primarily of the hepatocyte-specific mir122 has also emerged. In addition to the Barcelona Clinic Liver Cancer (BCLC) staging classification which determines the course of therapy, the molecular classification of HCC is based on key molecular alterations, many of which are observable in all HCC cases, whereas some alterations are only detectable in certain tumors.

Original languageHungarian
Pages (from-to)982-989
Number of pages8
JournalOrvosi Hetilap
Volume151
Issue number24
DOIs
Publication statusPublished - Jun 1 2010

Fingerprint

Molecular Pathology
Hepatocellular Carcinoma
Hepatocytes
Fibrosis
Agrin
Glypicans
Claudins
Neoplasms
Neoplasm Staging
alpha-Fetoproteins
Liver Neoplasms
Tumor Biomarkers
MicroRNAs
Antigens

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A hepatocellularis carcinoma - A makroszkópiától a molekuláris patológiáig. / Schaff, Z.; Kovalszky, I.; Lotz, G.; Kiss, András.

In: Orvosi Hetilap, Vol. 151, No. 24, 01.06.2010, p. 982-989.

Research output: Contribution to journalArticle

@article{c8f0d59f07714d2dbe87ccbcfd03b728,
title = "A hepatocellularis carcinoma - A makroszk{\'o}pi{\'a}t{\'o}l a molekul{\'a}ris patol{\'o}gi{\'a}ig",
abstract = "Hepatocellular carcinoma (HCC) is a tumor with rather bad prognosis. Recent years, however, have seen considerable progress in the diagnostics and treatment of this disease, contributing to better understanding of its molecular pathogenesis. Large regenerative nodules, low and high grade dysplastic nodules are premalignant alterations of HCC developing on the grounds of cirrhosis. Microscopically the WHO distinguishes trabecular, acinar (pseudoglandular), scirrhous and solid forms. Special histological subtypes are the clear cell, fibrolamellar and mixed hepato-cholangiocellular variants. The prognostic significance of these histological types is argued. The fibrolamellar, non-cirrhotic form of HCC occurring in young age is considered to be of better prognosis, but this is probably due to the fact that this type is not accompanied by cirrhosis. Certain tumor markers may help the diagnosis, such as alpha-fetoprotein (AFP), glypican-3, survivin, the recently described agrin and claudins, furthermore, the hepatocyte specific antigen (HSA), which confirms the hepatocytic origin of the tumor. Recently, the diagnostic significance of microRNAs, primarily of the hepatocyte-specific mir122 has also emerged. In addition to the Barcelona Clinic Liver Cancer (BCLC) staging classification which determines the course of therapy, the molecular classification of HCC is based on key molecular alterations, many of which are observable in all HCC cases, whereas some alterations are only detectable in certain tumors.",
keywords = "Hepatitis B virus, Hepatitis C virus, Hepatocellular carcinoma",
author = "Z. Schaff and I. Kovalszky and G. Lotz and Andr{\'a}s Kiss",
year = "2010",
month = "6",
day = "1",
doi = "10.1556/OH.2010.28875",
language = "Hungarian",
volume = "151",
pages = "982--989",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "24",

}

TY - JOUR

T1 - A hepatocellularis carcinoma - A makroszkópiától a molekuláris patológiáig

AU - Schaff, Z.

AU - Kovalszky, I.

AU - Lotz, G.

AU - Kiss, András

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Hepatocellular carcinoma (HCC) is a tumor with rather bad prognosis. Recent years, however, have seen considerable progress in the diagnostics and treatment of this disease, contributing to better understanding of its molecular pathogenesis. Large regenerative nodules, low and high grade dysplastic nodules are premalignant alterations of HCC developing on the grounds of cirrhosis. Microscopically the WHO distinguishes trabecular, acinar (pseudoglandular), scirrhous and solid forms. Special histological subtypes are the clear cell, fibrolamellar and mixed hepato-cholangiocellular variants. The prognostic significance of these histological types is argued. The fibrolamellar, non-cirrhotic form of HCC occurring in young age is considered to be of better prognosis, but this is probably due to the fact that this type is not accompanied by cirrhosis. Certain tumor markers may help the diagnosis, such as alpha-fetoprotein (AFP), glypican-3, survivin, the recently described agrin and claudins, furthermore, the hepatocyte specific antigen (HSA), which confirms the hepatocytic origin of the tumor. Recently, the diagnostic significance of microRNAs, primarily of the hepatocyte-specific mir122 has also emerged. In addition to the Barcelona Clinic Liver Cancer (BCLC) staging classification which determines the course of therapy, the molecular classification of HCC is based on key molecular alterations, many of which are observable in all HCC cases, whereas some alterations are only detectable in certain tumors.

AB - Hepatocellular carcinoma (HCC) is a tumor with rather bad prognosis. Recent years, however, have seen considerable progress in the diagnostics and treatment of this disease, contributing to better understanding of its molecular pathogenesis. Large regenerative nodules, low and high grade dysplastic nodules are premalignant alterations of HCC developing on the grounds of cirrhosis. Microscopically the WHO distinguishes trabecular, acinar (pseudoglandular), scirrhous and solid forms. Special histological subtypes are the clear cell, fibrolamellar and mixed hepato-cholangiocellular variants. The prognostic significance of these histological types is argued. The fibrolamellar, non-cirrhotic form of HCC occurring in young age is considered to be of better prognosis, but this is probably due to the fact that this type is not accompanied by cirrhosis. Certain tumor markers may help the diagnosis, such as alpha-fetoprotein (AFP), glypican-3, survivin, the recently described agrin and claudins, furthermore, the hepatocyte specific antigen (HSA), which confirms the hepatocytic origin of the tumor. Recently, the diagnostic significance of microRNAs, primarily of the hepatocyte-specific mir122 has also emerged. In addition to the Barcelona Clinic Liver Cancer (BCLC) staging classification which determines the course of therapy, the molecular classification of HCC is based on key molecular alterations, many of which are observable in all HCC cases, whereas some alterations are only detectable in certain tumors.

KW - Hepatitis B virus

KW - Hepatitis C virus

KW - Hepatocellular carcinoma

UR - http://www.scopus.com/inward/record.url?scp=77953225117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953225117&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28875

DO - 10.1556/OH.2010.28875

M3 - Article

C2 - 20519181

AN - SCOPUS:77953225117

VL - 151

SP - 982

EP - 989

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 24

ER -